Stockscreener 앱 받기
36.56
1.22%
-0.45
전일 마감가:
$37.01
열려 있는:
$37.32
하루 거래량:
30,044
Relative Volume:
1.09
시가총액:
$321.24M
수익:
$64.99M
순이익/손실:
$-4.30M
주가수익비율:
-34.82
EPS:
-1.05
순현금흐름:
$-3.51M
1주 성능:
-1.93%
1개월 성능:
+15.33%
6개월 성능:
+17.94%
1년 성능:
+17.82%
1일 변동 폭
$36.10
$37.32
1주일 범위
$36.10
$38.75
52주 변동 폭
$26.00
$43.25
Sanara Medtech Inc Stock (SMTI) Company Profile
명칭
Sanara Medtech Inc
전화
817-529-2300
주소
1200 SUMMIT AVE, FORT WORTH
SMTI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
36.56 | 321.24M | 64.99M | -4.30M | -3.51M | -1.05 |
|
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
|
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
|
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
|
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
|
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-05-20 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-06-30 | 개시 | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc 주식(SMTI)의 최신 뉴스
Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th - GlobeNewswire
Sanara MedTech to Present at Piper Sandler Healthcare Conference in December | SMTI Stock News - StockTitan
All You Need to Know About Sanara MedTech (SMTI) Rating Upgrade to Buy - MSN
Sanara MedTech Inc. (NASDAQ:SMTI) Shares Sold by Janney Montgomery Scott LLC - MarketBeat
US$44.00: That's What Analysts Think Sanara MedTech Inc. (NASDAQ:SMTI) Is Worth After Its Latest Results - Simply Wall St
Sanara MedTech Inc. (NASDAQ:SMTI) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
(SMTI) Investment Report - Stock Traders Daily
Earnings call: Sanara MedTech posts 35% revenue increase in Q3 - Investing.com India
Sanara MedTech Inc. (NASDAQ:SMTI) Q3 2024 Earnings Call Transcript - Insider Monkey
Sanara MedTech Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Sanara MedTech Inc (SMTI) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
Sanara MedTech Reports Strong Revenue Growth Amid Challenges - TipRanks
Sanara MedTech’s net revenue increases 35% in Q3 2024 - Medical Buyer
Sanara Medtech earnings beat by $0.28, revenue topped estimates - Investing.com Canada
Sanara MedTech Inc (SMTI) Q3 2024 Earnings: Revenue Surpasses Es - GuruFocus.com
Sanara MedTech Inc. Reports Third Quarter 2024 Results - The Manila Times
Sanara MedTech Reports 35% Revenue Surge to $21.7M, Marks 12th Straight Record Quarter | SMTI Stock News - StockTitan
Sanara MedTech Inc (SMTI) Q3 2024: Everything You Need To Know A - GuruFocus.com
Sanara MedTech (SMTI) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
(SMTI) Investment Analysis and Advice - Stock Traders Daily
Sanara MedTech Inc. (NASDAQ:SMTI) insiders have significant skin in the game with 30% ownership - Yahoo Finance
Sanara MedTech (NASDAQ:SMTI) Shares Up 1.5% – What’s Next? - Defense World
Sanara MedTech (NASDAQ:SMTI) Shares Up 1.5%Should You Buy? - MarketBeat
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates - GlobeNewswire
(SMTI) Investment Analysis - Stock Traders Daily
Retail investors who hold 32% of Sanara MedTech Inc. (NASDAQ:SMTI) gained 12%, insiders profited as well - Simply Wall St
Keith Myers named Sanara MedTech director - Medical Buyer
Sanara MedTech reshuffles board with new director - Investing.com
Sanara MedTech Board Evolution with Strategic New Appointment - TipRanks
Sanara MedTech Appoints Keith Myers to Board - citybiz
Sanara MedTech Inc. Announces Changes to Its Board of Directors - GlobeNewswire
InfuSystem, Sanara MedTech Partner For Distribution Deal - MPO-mag
InfuSystem, Sanara MedTech Partner for Distribution Deal - MPO-mag
(SMTI) On The My Stocks Page - Stock Traders Daily
Sanara MedTech (NASDAQ:SMTI) Trading Down 4.1% - Defense World
Analyzing Sanara MedTech (NASDAQ:SMTI) and Nutriband (NASDAQ:NTRB) - Defense World
Sanara MedTech Inc (SMTI) Shares Up 5.03% on Sep 27 - GuruFocus.com
Fort Worth health care company reaches compensation deal with new CEO - The Business Journals
Wound Cleanser Product Market to Surpass US$ 2.24 Billion, Expanding at a 1.4% CAGR by 2034: Fact.MR - GlobeNewswire Inc.
Sanara MedTech's (NASDAQ:SMTI) investors will be pleased with their solid 259% return over the last five years - Yahoo Finance
Sanara MedTech Inc. signs CEO Nixon to new employment terms - Investing.com India
Sanara MedTech Appoints Ronald T. Nixon as CEO with Incentive-Based Pay - TipRanks
Financial Analysis: Sanara MedTech (NASDAQ:SMTI) vs. Bone Biologics (NASDAQ:BBLG) - Defense World
Sanara MedTech Expands Portfolio with ChemoMouthpiece Investment - TipRanks
When (SMTI) Moves Investors should Listen - Stock Traders Daily
InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC - BioSpace
Sanara MedTech and InfuSystem execute U.S. distribution agreement - TipRanks
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce - GlobeNewswire
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC - StockTitan
Sanara Medtech Inc (SMTI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
자본화:
|
볼륨(24시간):